Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties from compounding the drug. Our FDA/Food, Drug & Device and Health Care Groups have...more
3/13/2025
/ Enforcement Actions ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Insurance ,
Life Sciences ,
Pharmaceutical Industry ,
Prescription Drugs ,
Regulatory Requirements ,
Supply Chain ,
Telehealth ,
Telemedicine
Our Health Care Group breaks down two California bills (SB 351 and AB 1415) that would regulate private equity’s and hedge funds’ roles in managing health care and dental practices....more
3/6/2025
/ Business Entities ,
California ,
Dental Practice ,
Health Care Providers ,
Healthcare ,
Healthcare Facilities ,
Investors ,
New Legislation ,
Non-Compete Agreements ,
Private Equity ,
Regulatory Requirements